Instantly™ is the first on-demand platform dedicated to helping brand researchers and marketers fully realize their potential by leading them to better decision making. Combining research expertise and technology, Instantly provides its clients the latest in consumer insights, market research, and product trends.
In an article titled “What We’re Reading This Week,” the Instantly™ editors highlighted three key stories released this week, one of which was “Predicted Market Research Trends for 2016” by the Market Research Blog.
As President/CEO of one of the first and only market research firm dedicated to stem cell markets, I was honored to be quoted by Instantly™ in their summary of this article. Specifically, the article reads:
“This article looked to industry executives and leaders for their expectations for the rest of the year. It seems that a large focus of 2016 will revolve around mobile. As Cade Hildreth, president/CEO of Bioinformant.com, points out, ‘For the first time in history, the average daily time that people spend consuming digital content has now surpassed the average time spent watching TV.'”
Too see the full article on the Instantly™ blog, click here:
https://blog.instant.ly/blog/2016/01/wwartw1416/. Or, learn more about my thoughts on the consumption of digital content in 2016 by viewing the post “3 Key Market Research Predictions for 2016.”
Is your market research provider actively studying trends in market research and adopting futuristic techniques? If they are not, they should be!
Want to be better informed than your competition? Get future stem cell industry updates.
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant has been featured on news outlets including the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Becton Dickinson, and Thermo Fisher Scientific, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.